Corrigendum to "A systematic review of higher-risk myelodysplastic syndromes clinical trials to determine the benchmark of azacitidine and explore alternative endpoints for overall survival" [Leukemia Res. 104 March (2021)]. (June 2021)

Record Type:: Journal Article
Title:: Corrigendum to "A systematic review of higher-risk myelodysplastic syndromes clinical trials to determine the benchmark of azacitidine and explore alternative endpoints for overall survival" [Leukemia Res. 104 March (2021)]. (June 2021)
Main Title:: Corrigendum to "A systematic review of higher-risk myelodysplastic syndromes clinical trials to determine the benchmark of azacitidine and explore alternative endpoints for overall survival" [Leukemia Res. 104 March (2021)]
Authors:: Garcia, Jacqueline S.
Swords, Ronan T.
Roboz, Gail J.
Jacoby, Meagan A.
Garcia-Manero, Guillermo
Hong, Wan-Jen
Yang, Xiaoqing
Zhou, Ying
Platzbecker, Uwe
Steensma, David P.
Wolff, Johannes E.
Fenaux, Pierre
Abstract:
Is Part Of:: Leukemia research. Volume 105(2021)
Journal:: Leukemia research
Issue:: Volume 105(2021)
Issue Display:: Volume 105, Issue 2021 (2021)
Year:: 2021
Volume:: 105
Issue:: 2021
Issue Sort Value:: 2021-0105-2021-0000
Page Start:
Page End:
Publication Date:: 2021-06
Subjects:: Leukemia -- Periodicals
Leukemia -- Periodicals
Leucémie -- Périodiques
Leukemia
Periodicals
Electronic journals
Electronic journals
616.9941905
Journal URLs:: http://www.sciencedirect.com/science/journal/01452126 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.leukres.2021.106581 ↗
Languages:: English
ISSNs:: 0145-2126
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5185.270000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 16886.xml